BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Claus BB, Specka M, McAnally H, Scherbaum N, Schifano F, Bonnet U. Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor? Front Psychiatry 2020;11:598150. [PMID: 33343424 DOI: 10.3389/fpsyt.2020.598150] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Yadav-samudrala BJ, Gorman BL, Dodson H, Ramineni S, Wallace D, Peace MR, Poklis JL, Jiang W, Fitting S. Effects of acute Δ9 -tetrahydrocannabinol on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice.. [DOI: 10.21203/rs.3.rs-2401488/v1] [Reference Citation Analysis]
2 Connor JP, Stjepanović D, Budney AJ, Le Foll B, Hall WD. Clinical management of cannabis withdrawal. Addiction 2022;117:2075-95. [PMID: 34791767 DOI: 10.1111/add.15743] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]